. "APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press, 1995.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
9:30
Determining Vaccine Need
Moderator: Samuel Katz, Steering Committee Member
Epidemiologic Data Gaps and Their Relevance to Vaccine Studies
Mark Steinhoff, Johns Hopkins University
The Situation in Nigeria and the United Arab Emirates
Catherine Oyejide, College of Medicine, Ibadan, Nigeria
Serotype Surprise: The Case of Haemophilus influenzae in Egypt
Mona Assad, VACSERA, Cairo, Egypt
The Global Burden of N. menigitidis-Caused Meningitis
Jay Wenger, Centers for Disease Control and Prevention
10:30
Break
10:45
Discussion
11:45
Lunch
12:45
Overcoming Technologic Barriers
Moderator: Emil Gotschlich, Rockefeller University
Pneumococcal Conjugate Vaccines: Status and Prospects
John La Montagne, National Institutes of Health
The Limits of Conjugate Technology
Philip Russell, Children’s Vaccine Initiative
The Common-Antigen Approach to Vaccine Development
David Briles, University of Alabama
1:30
Discussion
2:30
Break
2:45
A Meningococcal B Vaccine for Children
Wendell Zollinger, Walter Reed Army Institute of Research
